• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼻咽癌的晚期毒性、放疗技术的发展与生活质量

Late toxicity, evolving radiotherapy techniques, and quality of life in nasopharyngeal carcinoma.

作者信息

Lastrucci Luciana, Bertocci Silvia, Bini Vittorio, Borghesi Simona, De Majo Roberta, Rampini Andrea, Pernici Paola, Gennari Pietro Giovanni

机构信息

Unit of Radiation Oncology, San Donato Hospital, Arezzo, Italy.

Department of Medicine Section of Internal Medicine Endocrine and Metabolic Sciences, University of Perugia, Perugia, Italy.

出版信息

Radiol Med. 2017 Apr;122(4):303-308. doi: 10.1007/s11547-016-0722-6. Epub 2017 Jan 9.

DOI:10.1007/s11547-016-0722-6
PMID:28070838
Abstract

PURPOSE

To analyze quality of life (QoL) and functional state (FS) by patient-reported outcome (PRO) questionnaires (FACT-G, FACT-NP, PSS-HN, XeQOLS, and EQ-5D-3L) in long-term survivors nasopharyngeal carcinoma (NPC) treated with conventional radiotherapy (RT) and intensity modulated radiotherapy (IMRT).

METHODS

25 patients answered to five questionnaires about QoL and FS. All patients were assessed also for late toxicity.

RESULTS

Functional Assessment of Cancer Therapy-General (FACT-G) and Performance Status Scale Head and Neck (PSS-HN) scores were significantly elevated (better QoL) in age <50 years (p = 0.03). PSS-HN score was higher in IMRT group. The observed xerostomia was lower in the IMRT group and in patients who received conventional RT had worse QoL according to XeQOLS (University of Michigan Xerostomia-Related Quality of Life Scale) score questionnaire. Lower PSS-HN score and higher XeQOLS score were significantly related with the late xerostomia (p = 0.009 and 0.002, respectively).

CONCLUSIONS

Our preliminary data suggest that age, older techniques, xerostomia, and hearing loss are negative predictors of QoL.

摘要

目的

通过患者报告结局(PRO)问卷(FACT-G、FACT-NP、PSS-HN、XeQOLS和EQ-5D-3L)分析接受传统放疗(RT)和调强放疗(IMRT)的鼻咽癌(NPC)长期幸存者的生活质量(QoL)和功能状态(FS)。

方法

25名患者回答了关于QoL和FS的五份问卷。所有患者还接受了晚期毒性评估。

结果

年龄<50岁的患者癌症治疗通用功能评估(FACT-G)和头颈部性能状态量表(PSS-HN)得分显著升高(生活质量更好)(p = 0.03)。IMRT组的PSS-HN得分更高。根据XeQOLS(密歇根大学口干相关生活质量量表)得分问卷,IMRT组观察到的口干情况较少,接受传统放疗的患者生活质量较差。较低的PSS-HN得分和较高的XeQOLS得分与晚期口干显著相关(分别为p = 0.009和0.002)。

结论

我们的初步数据表明,年龄、较旧的技术、口干和听力损失是生活质量的负面预测因素。

相似文献

1
Late toxicity, evolving radiotherapy techniques, and quality of life in nasopharyngeal carcinoma.鼻咽癌的晚期毒性、放疗技术的发展与生活质量
Radiol Med. 2017 Apr;122(4):303-308. doi: 10.1007/s11547-016-0722-6. Epub 2017 Jan 9.
2
Long-term late toxicities and quality of life for survivors of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy versus non-intensity-modulated radiotherapy.调强放疗与非调强放疗治疗鼻咽癌幸存者的长期晚期毒性反应及生活质量
Head Neck. 2016 Apr;38 Suppl 1:E1026-32. doi: 10.1002/hed.24150. Epub 2015 Jul 18.
3
Long-Term Late Toxicity, Quality of Life, and Emotional Distress in Patients With Nasopharyngeal Carcinoma Treated With Intensity Modulated Radiation Therapy.调强放疗治疗鼻咽癌患者的长期迟发性毒性、生活质量和情绪困扰。
Int J Radiat Oncol Biol Phys. 2018 Oct 1;102(2):340-352. doi: 10.1016/j.ijrobp.2018.05.060. Epub 2018 Jun 4.
4
Intensity-modulated or conformal radiotherapy improves the quality of life of patients with nasopharyngeal carcinoma: comparisons of four radiotherapy techniques.调强放疗或适形放疗可改善鼻咽癌患者的生活质量:四种放疗技术的比较
Cancer. 2007 Jan 15;109(2):313-21. doi: 10.1002/cncr.22396.
5
Analysis of late toxicity in nasopharyngeal carcinoma patients treated with intensity modulated radiation therapy.调强放射治疗鼻咽癌患者的晚期毒性分析。
Radiat Oncol. 2015 Jan 13;10:17. doi: 10.1186/s13014-014-0326-z.
6
Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report.头颈部癌调强放疗或标准放疗后生活质量与口干症的配对病例对照研究:初步报告
Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):725-31. doi: 10.1016/j.ijrobp.2005.02.045.
7
Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.869例鼻咽癌患者接受根治性调强放疗的治疗结果及晚期毒性反应:顺铂总剂量及放疗增敏价值的新见解
Oncotarget. 2015 Nov 10;6(35):38381-97. doi: 10.18632/oncotarget.5420.
8
Intensity-modulated radiotherapy provides better quality of life than two-dimensional conventional radiotherapy for patients with stage II nasopharyngeal carcinoma.对于II期鼻咽癌患者,调强放疗比二维传统放疗能提供更好的生活质量。
Oncotarget. 2017 Jul 11;8(28):46211-46218. doi: 10.18632/oncotarget.17582.
9
Outcomes of xerostomia-related quality of life for nasopharyngeal carcinoma treated by IMRT: based on the EORTC QLQ-C30 and H&N35 questionnaires.调强放射治疗鼻咽癌患者口干相关生活质量的结局:基于欧洲癌症研究与治疗组织QLQ-C30和H&N35问卷
Expert Rev Anticancer Ther. 2015 Jan;15(1):109-19. doi: 10.1586/14737140.2015.961427. Epub 2014 Sep 18.
10
Replanning during intensity modulated radiation therapy improved quality of life in patients with nasopharyngeal carcinoma.调强放射治疗中的计划重订改善了鼻咽癌患者的生活质量。
Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):e47-54. doi: 10.1016/j.ijrobp.2012.09.033. Epub 2012 Nov 1.

引用本文的文献

1
Comparison of long-term quality of life and their predictors in survivors between paediatric and adult nasopharyngeal carcinoma in the intensity-modulated radiotherapy era.调强放疗时代儿童与成人鼻咽癌生存者长期生活质量的比较及其预测因素分析。
BMC Cancer. 2024 Oct 2;24(1):1223. doi: 10.1186/s12885-024-12966-4.
2
Impact of fosaprepitant in the prevention of nausea and emesis in head and neck cancer patients undergoing cisplatin-based chemoradiation: a pilot prospective study and a review of literature.顺铂为基础的放化疗的头颈部癌症患者中福沙匹坦预防恶心呕吐的影响:一项前瞻性研究和文献复习
Radiol Med. 2024 Mar;129(3):457-466. doi: 10.1007/s11547-024-01757-3. Epub 2024 Feb 14.
3

本文引用的文献

1
Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study.21世纪初在欧洲诊断出的头颈癌的预后与改善情况:基于人群的EUROCARE-5研究
Eur J Cancer. 2015 Oct;51(15):2130-2143. doi: 10.1016/j.ejca.2015.07.043. Epub 2015 Sep 26.
2
Impact of late toxicities on quality of life for survivors of nasopharyngeal carcinoma.晚期毒性对鼻咽癌幸存者生活质量的影响。
BMC Cancer. 2014 Nov 21;14:856. doi: 10.1186/1471-2407-14-856.
3
Outcomes of xerostomia-related quality of life for nasopharyngeal carcinoma treated by IMRT: based on the EORTC QLQ-C30 and H&N35 questionnaires.
Impact of radiation dose on patient-reported acute taste alteration in a prospective observational study cohort in head and neck squamous cell cancer (HNSCC).
前瞻性观察研究队列中头颈部鳞状细胞癌(HNSCC)患者报告的急性味觉改变与辐射剂量的影响。
Radiol Med. 2023 Dec;128(12):1571-1579. doi: 10.1007/s11547-023-01707-5. Epub 2023 Aug 29.
4
Quality of life among female childhood cancer survivors with and without premature ovarian insufficiency.有和没有卵巢早衰的女性儿童癌症幸存者的生活质量。
J Cancer Surviv. 2023 Feb;17(1):101-109. doi: 10.1007/s11764-021-00987-y. Epub 2021 Jan 19.
5
Early Stage Markers of Late Delayed Neurocognitive Decline Using Diffusion Kurtosis Imaging of Temporal Lobe in Nasopharyngeal Carcinoma Patients.利用鼻咽癌患者颞叶扩散峰度成像检测晚期延迟神经认知功能下降的早期标志物
J Cancer. 2020 Aug 25;11(20):6168-6177. doi: 10.7150/jca.48759. eCollection 2020.
6
Quality of Life, Toxicity and Unmet Needs in Nasopharyngeal Cancer Survivors.鼻咽癌幸存者的生活质量、毒性反应及未满足的需求
Front Oncol. 2020 Jun 12;10:930. doi: 10.3389/fonc.2020.00930. eCollection 2020.
7
Radiotherapy-induced dysphagia and its impact on quality of life in patients with nasopharyngeal carcinoma.放疗相关性吞咽困难及其对鼻咽癌患者生活质量的影响。
Strahlenther Onkol. 2019 Jun;195(6):457-467. doi: 10.1007/s00066-018-01421-6. Epub 2019 Jan 28.
8
Hearing loss and tinnitus in survivors with chemotherapy-induced neuropathy.化疗引起的神经病变幸存者的听力丧失和耳鸣
Eur J Oncol Nurs. 2018 Feb;32:1-11. doi: 10.1016/j.ejon.2017.10.006. Epub 2017 Nov 7.
调强放射治疗鼻咽癌患者口干相关生活质量的结局:基于欧洲癌症研究与治疗组织QLQ-C30和H&N35问卷
Expert Rev Anticancer Ther. 2015 Jan;15(1):109-19. doi: 10.1586/14737140.2015.961427. Epub 2014 Sep 18.
4
Concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: treatment outcomes of a prospective, multicentric clinical study.局部晚期鼻咽癌同步放化疗:一项前瞻性多中心临床研究的治疗结果
Radiother Oncol. 2014 Jul;112(1):106-11. doi: 10.1016/j.radonc.2014.05.005. Epub 2014 Jun 2.
5
Health related quality of life in head and neck cancer treated with radiation therapy with or without chemotherapy: a systematic review.接受或未接受化疗的放射治疗的头颈癌患者的健康相关生活质量:一项系统评价
Oral Oncol. 2014 Apr;50(4):254-62. doi: 10.1016/j.oraloncology.2014.01.015. Epub 2014 Feb 18.
6
Study protocol for valuing EQ-5D-3L and EORTC-8D health states in a representative population sample in Sri Lanka.斯里兰卡代表性人群样本中 EQ-5D-3L 和 EORTC-8D 健康状态的价值评估研究方案。
Health Qual Life Outcomes. 2013 Sep 2;11:149. doi: 10.1186/1477-7525-11-149.
7
Combined chemo-radiotherapy in locally advanced nasopharyngeal carcinomas.局部晚期鼻咽癌的放化疗联合治疗
World J Clin Oncol. 2013 May 10;4(2):47-51. doi: 10.5306/wjco.v4.i2.47.
8
Current management of nasopharyngeal cancer.鼻咽癌的现行治疗方法。
Semin Radiat Oncol. 2012 Jul;22(3):233-44. doi: 10.1016/j.semradonc.2012.03.008.
9
Role of plasma EBV DNA levels in predicting recurrence of nasopharyngeal carcinoma in a Western population.血浆 EBV DNA 水平在预测西方人群鼻咽癌复发中的作用。
BMC Cancer. 2012 May 30;12:208. doi: 10.1186/1471-2407-12-208.
10
Multivariate analysis of quality of life outcome for nasopharyngeal carcinoma patients after treatment.鼻咽癌患者治疗后生活质量结局的多变量分析。
Radiother Oncol. 2010 Nov;97(2):263-9. doi: 10.1016/j.radonc.2010.05.022.